HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

caN protocol

consisting of above cpds; used for treatment of advanced non-small-cell lung cancer

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - caN protocol: 1
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - caN protocol: 1
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - caN protocol: 1
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Indole Alkaloids: 200
    - Secologanin Tryptamine Alkaloids: 81
      - Vinca Alkaloids: 463
        Vinblastine: 3373
        caN protocol: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vinblastine: 3373
        caN protocol: 1
    - Indolizines: 3
      - Indolizidines: 2
        Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vinblastine: 3373
        caN protocol: 1
Organic Chemicals: 133
- Coordination Complexes: 576
  - Carboplatin: 10368
    - caN protocol: 1

Experts

1.	Colombo, M: 1 article (04/2010)
2.	Donato, M F: 1 article (04/2010)
3.	Rigamonti, C: 1 article (04/2010)

Related Diseases

1.	Hepatitis C 04/01/2010 - "Can protocol liver biopsy be avoided to evaluate post-transplant hepatitis C recurrence? "